Cardiopulmonary Stress Testing Systems Market Expected to Progress from US$3.3 Bn in 2014 to US$6.6 Bn by 2023 Owing to Rising Obesity
The global cardiopulmonary stress testing systems market consists of devices that evaluate the exercise capacity of individuals to predict the outcome in people detected with heart failure. The primary aim of cardiac stress testing is to detect the risk stratification of CAD, which is a common cause of deaths across the globe. Over the past few years, a lot of importance has been given to the detection and monitoring of cardiopulmonary disorders. The global rise in the number of healthcare...
View full press release